Esperion Therapeutics, Inc. (ESPR): Price and Financial Metrics
Esperion Therapeutics, Inc. (ESPR)
Today's Latest Price: $30.79 USD
Updated Oct 28 11:07am
Add ESPR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ESPR Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for ESPR is 2.53 -- better than 78.18% of US stocks.
- ESPR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 86.73% of US stocks.
- As for revenue growth, note that ESPR's revenue has grown 47.57% over the past 12 months; that beats the revenue growth of 89.56% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Esperion Therapeutics Inc, a group of peers worth examining would be NPTN, ALRM, EXEL, SMCI, and NVMI.
- Visit ESPR's SEC page to see the company's official filings. To visit the company's web site, go to www.esperion.com.
ESPR Stock Price Chart Interactive Chart >
ESPR Price/Volume Stats
| Current price | $30.79 | 52-week high | $76.98 |
| Prev. close | $31.40 | 52-week low | $24.82 |
| Day low | $30.10 | Volume | 162,482 |
| Day high | $31.14 | Avg. volume | 696,968 |
| 50-day MA | $35.03 | Dividend yield | N/A |
| 200-day MA | $42.86 | Market Cap | 856.73M |
Esperion Therapeutics, Inc. (ESPR) Company Bio
Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.
Loading social stream, please wait...